公司资料
Indaptus Therapeutics 股价、新闻与催化剂
- 股票代码:
- INDP
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.00 USD (-6.54%)
收盘价
最后更新: 2026年8月17日
243M USD
市值
股价为何变动
As of Aug 17, 2026, INDP closed down 6.54% at $1.00. No new same-company headline was identified in the current news window.
公司概览
Immunotherapy Research Company
Indaptus Therapeutics developed the Decoy platform, a systemic immunotherapy approach designed to activate multiple innate and adaptive immune pathways.
Decoy20
Decoy20 is a killed, attenuated bacterial product intended to stimulate broad antitumor immunity. Indaptus has discontinued enrollment and currently has no patients in active Decoy20 clinical studies.
Strategic Review
The company has reduced Decoy20 development activities and is evaluating research collaborations, strategic investments, acquisitions, and other potential business combinations.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。